Reimbursement FAQs: IBD, Outpatient Infusion Centers and Employer Carrier Changes
Reimbursement rates for infusion medications; reimbursement process for infusion centers; and what to do if when employer carrier changes result in denied coverage.
Reimbursement FAQs: ICD-9 Codes and Nursing Services
Exploring the new ICD-9 code for acquired hemophilia and Medicare reimbursement for in-home nursing services.
Reimbursement FAQs: SCIG Prescription Benefit and Vial Size
Addressing questions regarding reimbursement for subcutaneous immune globulin in patients with primary immunodeficiency.
The Drug Shortage Crisis
The drug shortage crisis has been referred to as “a tsunami of medical risk,” and there is no sign that the problem will disappear in the near future.
Reimbursement FAQs: IVIG Access, Specialty Tiers, Drug Shortages and More
Several advocacy groups are focusing their efforts on reimbursement issues that they believe threaten patients’ access to care.
Immune Globulin Reimbursement
A high-cost therapy coupled with a complex and evolving reimbursement model has created what some are calling a healthcare crisis for tens of thousands of chronically ill patients.
Reimbursement FAQs: Patient Affordability Programs
Some commonly held misunderstandings about reimbursement are clarified, including reimbursement for IVIG, SCIG, affordability and assistance.
Reimbursement FAQs: SCIG and Vaccines
Clearing up common misunderstandings about reimbursement rates for subcutaneous immune globulin therapy and vaccine costs.
IVIG: The Evolution of the Manufacturing Process
Modifications in the steps and ingredients of the manufacturing process of immune globulin have changed the world of immune therapy.
New Transparency Reporting Guidelines Affecting Physicians
The healthcare reform laws include new strict reporting guidelines for the medical industry, and physicians need to ensure that what is reported is correct to protect their practice.